42822-13-9

Upstream product

• 131524-28-2 methyl 2-O-allyl-3,4-di-O-benzyl-α-L-fucopyranoside 

Downstream Products

• 1415117-96-2 {2,3-diberezyl-4-acetyl L-fucose}-alpha-1-4-[2',3'-dibenzyl 6'-acetyl-glucose]-beta-1-2(3,4 dibenzyl alpha methyl L-fucose) 
• 1415117-95-1 2',3'-dibenzyl-6'-acetyl D-glucose beta-1-2(3,4-dibenzyl alpha methyl L-fucose) 
• 1415117-94-0 2',3'-dibenzoyl D-glucose beta-1-2(3,4-dibenzyl alpha methyl L-fucose) 
• 1415117-93-9 4',6'-benzylidene D-glucose beta-1-2(3,4 dibenzyl alpha methyl L-fucose) 
• 130572-09-7 (2S,3S,4S,5R,6S)-4,5-Bis-benzyloxy-2-((2R,3S,4R,5R,6S)-4,5-bis-benzyloxy-2-methoxy-6-methyl-tetrahydro-pyran-3-yloxy)-6-methyl-tetrahydro-pyran-3-ol 
• 131524-36-2 methyl-3,4-di-O-benzyl-2-O-(sodium 2,3-di-O-benzyl-α-L-fucopyranosyl 4-sulfate)-α-L-fucopyranoside 
• 131524-33-9 methyl 3,4-di-O-benzyl-2-O-(sodium 4-O-acetyl-2-O-benzyl-α-L-fucopyranosyl 3-sulfate)-α-L-fucopyranoside 
• 131524-35-1 methyl 3,4-di-O-benzyl-2-O-(2,3-di-O-benzyl-α-L-fucopyranosyl)-α-L-fucopyranoside 
• 131524-32-8 methyl 2-O-(4-O-acetyl-2-O-benzyl-α-L-fucopyranosyl)-3,4-di-O-benzyl-α-L-fucopyranoside 
• 131524-31-7 methyl 3,4-di-O-benzyl-2-O-<2-O-benzyl-α-L-fucopyranosyl>-α-L-fucopyranoside 
• 130572-08-6 C₄₄H₅₂O₉ 
• 130597-54-5 C₄₄H₅₂O₉ 
• 131524-30-6 methyl 3,4-di-O-benzyl-2-O-<2-O-benzyl-3,4-O-isopropylidene-α-L-fucopyranosyl>-α-L-fucopyranoside 
• 131524-29-3 methyl 3,4-di-O-benzyl-2-O-<2-O-benzyl-3,4-O-isopropylidene-β-L-fucopyranosyl>-α-L-fucopyranoside 

Relevant academic research and scientific papers

SULFATED OLIGOSACCHARIDES FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES

Compounds which interact with HlsTONES Compounds of Formula I : ? 4"'-Sulfo-Fucose [alpha]1-3 (4"-sulfo)-Fucose [alpha]1-3 (4'-Sulfo-Fu- cose [alpha]1-4-Glucuronic acid [beta]1-0-Methyl or ? 4" "-Sulfo-Fucose [alpha]1-3 (4"-sulfo)-Fucose [alpha